MicroAlgo (VENAF) Cash & Equivalents (2020 - 2025)

MicroAlgo (VENAF) has 6 years of Cash & Equivalents data on file, last reported at $173.3 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents rose 20.15% year-over-year to $173.3 million; the trailing twelve-month figure through Dec 2025 stood at $173.3 million (up 20.15% YoY), and the FY2025 full-year result was $174.8 million, up 21.33% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $173.3 million, down from $253.3 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $253.3 million in Q2 2025 and bottomed at $2643.0 in Q3 2021.
• The 5-year median for Cash & Equivalents is $21.0 million (2023), against an average of $53.4 million.
• The widest annual swing landed in 2021, when Cash & Equivalents soared 17874291.21%; it then plunged 86.47% in 2022.
• A 5-year view of Cash & Equivalents shows it stood at $42.7 million in 2021, then dropped by 2.01% to $41.9 million in 2022, then rose by 5.25% to $44.1 million in 2023, then jumped by 227.35% to $144.2 million in 2024, then rose by 20.15% to $173.3 million in 2025.
• The last three Cash & Equivalents figures came in at $173.3 million (Q4 2025), $253.3 million (Q2 2025), and $144.2 million (Q4 2024), per Business Quant data.

Peer Comparison